REQUEST A DEMO
Total
USD $0.00
Search more companies

Signova Pharma Private Limited (India)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Signova Pharma Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Signova Pharma Private Limited is an unlisted company, incorporated on 04/01/2008. It has its registered office in the State of Assam, India. Company's corporate identification number (CIN) is U51397AS2008PTC008558 and registration number is 008558. The company is a trade company, it is engaged in wholesale trading.

Legal Address
House No-44, Ground Floor, Barthakur Mill Road Ulubari
Kamrup; Assam; Postal Code: 781007

Contact Details: Purchase the Signova Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Signova Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Signova Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Signova Pharma Private Limited report to view the information.
Incorporation Date:
January 04, 2008
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
41.25%
Purchase this report to view the information.
40%
Subsidiaries
Signova Healthcare Private Limited
38.35%
Company Performance
Financial values in the chart are available after Signova Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
38.34%
Total operating revenue
38.45%
Operating profit (EBIT)
18.76%
EBITDA
18.17%
Net Profit (Loss) for the Period
13.68%
Total assets
55.44%
Total equity
37.14%
Operating Profit Margin (ROS)
-1.1%
Net Profit Margin
-1.03%
Return on Equity (ROE)
-5.05%
Debt to Equity Ratio
34.28%
Quick Ratio
-0.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?